Skip to main content
SpringerLink
Log in

Lithiumaugmentation

  • Conference paper
Therapieresistente Depressionen

Zusammenfassung

  1. 1.

    Unter Lithiumaugmentation versteht man die Hinzugabe von Lithium zu einem Antidepressivum in der Akuttherapie depressiver Patienten nach Non-Response auf eine antidepressive Monotherapie.

  2. 2.

    Seit der Erstbeschreibung von de Montigny 1981 wurde die Lithiumaugmentation bis heute in ca. 30 prospektiven Studien bei etwa-500 depres siven Patienten untersucht. Die Wirksamkeit dieses Verfahrens wurde mit allen gängigen Antidepressiva-Substanzklassen überprüft (u.a. Trizyklika, SSRIs, MAO-Hemmer). Eine Meta-Analyse der Plazebo-kon trollierten Doppelblindstudien zeigte, daß die Zugabe von Lithium zum Antidepressivum signifikant wirksamer als Plazebo ist.

  3. 3.

    Nach einer raschen Aufdosierung (1. Tag: 12 mmol, ab 2. Tag 18 – 24 mmol) sollte ein Lithium-Serumspiegel von 0.5 – 0.8 mmol/1 nach der ersten Behandlungswoche angestrebt werden.

  4. 4.

    Etwa 50 – 60% der therapieresistenten depressiven Patienten respon-dieren auf die Lithiumzugabe innerhalb von 2 – 6 Wochen. Bei ca. einem Fünftel der Responder kommt es bereits innerhalb der ersten zwei bis vier Tage nach Lithiumzugabe zu einer klinisch relevanten Symptomreduktion bis hin zur Vollremission. Das Verfahren besitzt deshalb einen hohen Stellenwert in der Behandlung therapierefraktärer Patienten.

  5. 5.

    Aufgrund der guten Verträglichkeit kann die Lithiumaugmentation auch bei älteren Patienten empfohlen werden, wobei lediglich der verminderten Clearance durch etwas niedrigere Lithium-Serumspiegel (0.4 – 0.6 mmol/1) Rechnung getragen werden sollte.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • American Psychiatric Association (1994) Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 151:( Suppl. Dec ): 1–36

    Google Scholar 

  • Apter JT, Woolfolk RL (1990) Lithium augmentation of bupropion in refractory depression. Ann Clin Psychiatry 2: 7–10

    Article  Google Scholar 

  • Bauer M (1995) The combined use of lithium and SSRIs. J Serotonin Res 2: 69–76

    CAS  Google Scholar 

  • Bauer M, Ahrens B (1996) Bipolar disorder: A practical guide to drug treatment. CNS Drugs 6 (1): 35–52

    Article  CAS  Google Scholar 

  • Bauer M, Döpfmer S. Lithiumaugmentation in refractory depression: Meta-analysis of placebo-controlled studies. Manuskript in Vorbereitung

    Google Scholar 

  • Bauer M, Kunz D, Ströhle A, Müller-Oerlinghausen B (1995) What is the optimal duration of lithiumaugmentation in refractory depression? Preliminary results from a controlled trial. Pharmacopsychiatry 26: 163 (Abstract)

    Google Scholar 

  • Bauer M, Linden M, Schaaf B, Weber HJ (1996) Adverse events and tolerability of the combina- tion of fluoxetine/lithium compared with fluoxetine. J Clin Psychopharmacol 16: 130–134

    Article  PubMed  CAS  Google Scholar 

  • Baxter LR, Liston EH, Schwartz JM, Altshuler LL, Wilkins JN, Richeimer S, Guze BH (1986) Prolongation of the antidepressant response to partial sleep deprivation by lithium. Psychiatry Res 19: 17–23

    Article  PubMed  Google Scholar 

  • Blier P, de Montigny C, Chaput Y (1987) Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression. J Clin Psychopharmacol 7: 24–35

    Google Scholar 

  • Ciraulo DA, Shader RI, Greenblatt DJ, Creelman W (1995) Drug interactions in psychiatry. Williams & Wilkins, Baltimore

    Google Scholar 

  • Cournoyer G, de Montigny C, Ouellette J, Leblanc G, Langlois R, Elie R (1984) Lithium addition in tricyclic-resistant unipolar depression: a placebo-controlled study. Abstracts of Collegium Internationale Neuropsychopharmacologicum, Florence, Italy, June 19–23, p. 179

    Google Scholar 

  • Cowen PJ, McCance SL, Ware CJ, Cohen PR, Chalmers JS, Julier DL (1991) Lithium in tricyclic-resistant depression. Br J Psychiatry 159: 341–346

    Article  PubMed  CAS  Google Scholar 

  • Dallai A, Fontaine R, Ontiveros A, Elie R (1990) Lithium carbonate augmentation of desipramine in refractory depression. Can J Psychiatry 35: 608–611

    Google Scholar 

  • Devanand DP, Sackeim HA, Brown RP (1988) Myoclonus during combined tricyclic antidepressant and lithium treatment. J Clin Psychopharmacol 8: 446–447

    Article  PubMed  CAS  Google Scholar 

  • Dinan TG (1993) Lithium augmentation in sertraline-resistant depression: a preliminary dose-response study. Acta Psychiatr Scand 88: 300–301

    Article  PubMed  CAS  Google Scholar 

  • Dinan TG, Barry S (1989) A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 80: 97–100

    Article  PubMed  CAS  Google Scholar 

  • Evans M, Marwick P (1990) Fluvoxamine and lithium: an unusual interaction. Br J Psychiatry 156: 286 (letter)

    Google Scholar 

  • Fava M, Rosenbaum JF, McGrath PJ, Stewart JW, Amsterdam JD, Quitkin FM (1994) Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am J Psychiatry 151: 1372–1374

    PubMed  CAS  Google Scholar 

  • Fein S, Paz V, Rao N, LaGrassa J (1988) The combination of lithium carbonate and a MAOI in refractory depressions. Am J Psychiatry 145: 249–250

    PubMed  CAS  Google Scholar 

  • Finch EJL, Katona CLE (1989) Lithium augmentation in the treatment of refractory depression in old age. Int J Geriatric Psychiatry 4: 41–46

    Article  Google Scholar 

  • Flint A (1992) Lithium augmentation in antidepressant-resistant patients. Br J Psychiatry 160: 710

    Article  PubMed  CAS  Google Scholar 

  • Flint AJ, Rifat SL (1994) A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. J Clin Psychopharmacol 14: 353–356

    Article  PubMed  CAS  Google Scholar 

  • Garbutt JC, Mayo JP, Gilette GM, Little KY, Mason GA (1986) Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation. Am J Psychiatry 143: 1038–1039

    PubMed  CAS  Google Scholar 

  • Ghadirian AM, Kusalic M (1990) Rapid cycling following antidepressant in an adolescent. Biol Psychiatry 27: 1183–1184

    Article  PubMed  Google Scholar 

  • Goodwin FK, Jamison KR (1990) Manic-depressive illness. Oxford University Press, Oxford

    Google Scholar 

  • Hawley CJ, Roberts AG, Baldwin DS (1994b) Tolerability of combined treatment with lithium and fluoxetine: 14 cases treated under open conditions. Int Clin Psychopharmacol 9: 31–33

    Article  PubMed  CAS  Google Scholar 

  • Hawley CJ, Roberts AG, Walker MH (1994a) Tolerability of combined treatment with lithium and paroxetine: 19 cases treated under open conditions. J Psychopharmacol 8: 266–267

    Article  PubMed  CAS  Google Scholar 

  • Heninger GR, Charney DS, Sternberg DE (1983) Lithium carbonate augmentation of antidepressant treatment. Arch Gen Psychiatry 40: 1335–1342

    Article  PubMed  CAS  Google Scholar 

  • Hoencamp E, Haffmans PMJ, Dijken WA, Hoogduin CAL, Nolen WA, van Dyck R (1994) Brofaromine versus lithium addition to maprotiline. A double-blind study in maprotiline refractory depressed outpatients. J Affect Disorders 30: 219–227

    Google Scholar 

  • Joffe RT, Levitt AJ, Bagby RM, MacDonald C, Singer W (1993a) Predictors of response to lithium and triiodothyronine augmentation of antidepressants in tricyclic non-responders. Br J Psychiatry 163: 574–578

    Article  PubMed  CAS  Google Scholar 

  • Joffe RT, Singer W, Levitt AJ, MacDonald C (1993b) A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 50: 387–393

    Article  PubMed  CAS  Google Scholar 

  • Johnson FN (1991) Lithium augmentation therapy in depression. In: Johnson S, Johnson FN (eds) Reviews in Contemporary Pharmacotherapy, Vol 2, No 1, Marius Press, pp. 3–52

    Google Scholar 

  • Kantor D, McNevin S, Leichner P, Harper D, Krenn M (1986) The benefit of lithium carbonate adjunct in refractory depression–fact or fiction? Can J Psychiatry 31: 416–418

    PubMed  CAS  Google Scholar 

  • Katona CLE (1988) Lithium augmentation in refractory depression. Psychiatr Dev 2: 153–171

    Google Scholar 

  • Katona CLE, Abou-Saleh MT, Harrison DA, Nairac BA, Edwards DRL, Lock T, Burns RA, Robertson MM (1995) Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 166: 80–86

    Article  PubMed  CAS  Google Scholar 

  • Katona CLE, Finch EJL (1991) Lithium augmentation for refractory depression in old age. In: Amsterdam JD (ed) Advances in Neuropsychiatry and Psychopharmacology, Vol 2: Refractory Depression. Raven Press, New York, pp 177–184

    Google Scholar 

  • Kushnir SL (1986) Lithium-antidepressant combinations in the treatment of depressed, physically ill geriatric patients. Am J Psychiatry 143: 378–379

    PubMed  CAS  Google Scholar 

  • Louie AK, Meltzer HY (1984) Lithium potentiation of antidepressant treatment. J Clin Psychopharmacol 4: 316–321

    Article  PubMed  CAS  Google Scholar 

  • Mendels J (1976) Lithium in the treatment of depression. Am J Psychiatry 133 (4): 373–378

    PubMed  CAS  Google Scholar 

  • Montigny de C (1994) Lithium addition in refractory depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: Current strategies and future directions, John Wiley & Sons, Chichester, pp 47–57

    Google Scholar 

  • Montigny de C, Aghajanian GK (1978) Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202: 1303–1306

    Article  PubMed  Google Scholar 

  • Montigny de C, Cournoyer G, Morissette R (1983) Lithium carbonate addition in tricyclic antidepressant resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drug and lithium action on the serotonin system. Arch Gen Psychiatry 40: 1327–1334

    Google Scholar 

  • Montigny de C, Elie R, Caille G (1985) Rapid response to the addition of lithium in iprindoleresistant unipolar depression: a pilot study. Am J Psychiatry 142: 220–223

    PubMed  Google Scholar 

  • Montigny de C, Grunberg F, Mayer A, Deschenes JP (1981) Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 138: 252–256

    Article  PubMed  Google Scholar 

  • Muly EC, McDonald W, Steffens D (1993) Serotonin syndrome produced by a combination of fluoxetine and lithium. Am J Psychiatry 150: 1565 (letter)

    Google Scholar 

  • Noveske FG, Hahn KR, Flynn RJ (1989) Possible toxicity of combined fluoxetine and lithium. Am J Psychiatry 146: 1515 (letter)

    Google Scholar 

  • Ontiveros A, Fontaine R, Elie R (1991) Refractory depression: the addition of lithium to fluoxetine or desipramine. Acta Psychiatr Scand 83: 188–192

    Article  PubMed  CAS  Google Scholar 

  • Pai MA, White AC, Deane AG (1986) Lithium augmentation in the treatment of delusional depression. Br J Psychiatry 148: 736–738

    Article  PubMed  CAS  Google Scholar 

  • Peet M (1994) Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 164: 549–550

    Article  PubMed  CAS  Google Scholar 

  • Pope HG, McElroy SL, Nixon RA (1988) Possible synergism between fluoxetine and lithium in refractory depression. Am J Psychiatry 145: 1292–1294

    PubMed  Google Scholar 

  • Price LH (1989) What is the duration for augmentation with T3 or lithium in resistant depression? J Clin Psychopharmacol 9: 73

    Article  PubMed  CAS  Google Scholar 

  • Price LH, Charney DS, Heninger GR (1984) Manic symptoms following addition of lithium to antidepressant treatment. J Clin Psychopharmacol 4: 361–362

    Article  PubMed  CAS  Google Scholar 

  • Price LH, Charney DS, Heninger GR (1986) Variability of response to lithium augmentation in refractory depression. Am J Psychiatry 143: 1387–1392

    PubMed  CAS  Google Scholar 

  • Price LH, Conwell Y, Nelson JC (1983) Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Am J Psychiatry 140: 318–322

    PubMed  CAS  Google Scholar 

  • Schöpf J (1989) Lithiumzugabe zu Thymoleptika als Behandlung therapieresistenter Depressionen. Nervenarzt 60: 200–205

    PubMed  Google Scholar 

  • Schöpf J, Baumann P, Lemarchand T, Rey M (1989) Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study. Pharmacopsychiatry 22: 183–187

    Google Scholar 

  • Schou M (1990) Lithium and treatment-resistant depressions: a review. Lithium 1: 38

    Google Scholar 

  • Schou M (1995) Prophylactic lithium treatment of unipolar and bipolar manic-depressive illness. Psychopathology 28 (Suppl.): 81–85

    Article  PubMed  Google Scholar 

  • Souza FGM, Goodwin GM (1991) Lithium treatment and prophylaxis in unipolar depression: A meta-analysis. Br J Psychiatry 158: 666–675

    Google Scholar 

  • Stein G, Bernadt M (1993) Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses. Br J Psychiatry 162: 634–640

    Google Scholar 

  • Sternbach H (1991) The serotonin syndrome. Am J Psychiatry 148: 705–713

    PubMed  CAS  Google Scholar 

  • Terao T, Yoshimura R, Abe K (1990) Lithium potentiation of tetracyclic antidepressants. Biol Psychiatry 28: 1065–1080

    Article  Google Scholar 

  • Thase ME, Kupfer DJ, Frank E, Jarrett DB (1989) Treatment of imipramine-resistant recurrent depression: II. an open clinical trial of lithium augmentation. J Clin Psychiatry 50: 413–417

    Google Scholar 

  • Yuvarajan R, Yousufzai NM (1988) Mania induced by lithium augmentation. Br J Psychiatry 153: 828–830

    Article  PubMed  CAS  Google Scholar 

  • Zimmer B, Rosen J, Thornton JE, Perel JM, Reynolds CF (1991) Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients. J Clin Psychopharmacol n: 254–256

    Google Scholar 

  • Zusky PM, Biederman J, Rosenbaum JF, Manschreck TC, Gross CC, Weilberg JB, Gastfriend DR (1988) Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study. J Clin Psychopharmacol 8: 120–124

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. M. Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrische Klinik und Poliklinik, Freien Universität Berlin, Eschenallee 3, 14050, Berlin, Deutschland

    Michael Bauer  & Anne Berghöfer (Ärztin) &  (Ärztin)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Bauer, M. (1997). Lithiumaugmentation. In: Bauer, M., Berghöfer, A. (eds) Therapieresistente Depressionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10500-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10500-9_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61675-7

  • Online ISBN: 978-3-662-10500-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation